| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis.
|
Arthritis Rheum
|
2009
|
1.41
|
|
2
|
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.
|
J Rheumatol
|
2007
|
1.34
|
|
3
|
Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome.
|
Ann Rheum Dis
|
2011
|
1.18
|
|
4
|
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects.
|
Ann Rheum Dis
|
2006
|
1.16
|
|
5
|
Psoriatic Arthritis.
|
N Engl J Med
|
2017
|
1.09
|
|
6
|
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis.
|
Arthritis Rheum
|
2011
|
1.07
|
|
7
|
New approaches in the treatment of Adamantiades-Behçet's disease.
|
Curr Opin Rheumatol
|
2006
|
1.01
|
|
8
|
Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection.
|
J Rheumatol
|
2008
|
1.00
|
|
9
|
NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
|
Arthritis Rheum
|
2005
|
0.95
|
|
10
|
IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes.
|
Rheumatology (Oxford)
|
2013
|
0.94
|
|
11
|
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
|
Arthritis Res Ther
|
2013
|
0.93
|
|
12
|
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis.
|
Ann Rheum Dis
|
2012
|
0.93
|
|
13
|
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry.
|
Autoimmun Rev
|
2012
|
0.92
|
|
14
|
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
|
Arthritis Rheum
|
2004
|
0.89
|
|
15
|
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis.
|
Rheumatol Int
|
2009
|
0.89
|
|
16
|
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes?
|
Clin Dev Immunol
|
2011
|
0.87
|
|
17
|
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease.
|
Clin Exp Rheumatol
|
2010
|
0.86
|
|
18
|
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs.
|
Rheumatol Int
|
2009
|
0.86
|
|
19
|
Vascular endothelial growth factor gene polymorphisms in Behçet's disease.
|
J Rheumatol
|
2004
|
0.86
|
|
20
|
Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response.
|
Arthritis Rheum
|
2010
|
0.85
|
|
21
|
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome.
|
Ann Rheum Dis
|
2012
|
0.84
|
|
22
|
Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis.
|
Rheumatol Int
|
2009
|
0.84
|
|
23
|
Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis.
|
Rheumatology (Oxford)
|
2013
|
0.84
|
|
24
|
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS.
|
Expert Rev Clin Immunol
|
2013
|
0.84
|
|
25
|
Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity.
|
Arthritis Res Ther
|
2010
|
0.82
|
|
26
|
Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation.
|
Rheumatology (Oxford)
|
2010
|
0.82
|
|
27
|
Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis.
|
Arthritis Rheum
|
2011
|
0.81
|
|
28
|
Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
|
Clin Exp Rheumatol
|
2014
|
0.80
|
|
29
|
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients.
|
Rheumatology (Oxford)
|
2012
|
0.80
|
|
30
|
Cognitive impairment in Behçet's disease patients without overt neurological involvement.
|
J Neurol Sci
|
2004
|
0.79
|
|
31
|
Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype.
|
Biomed Pharmacother
|
2003
|
0.79
|
|
32
|
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease.
|
Rheumatology (Oxford)
|
2012
|
0.78
|
|
33
|
No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study.
|
Clin Exp Rheumatol
|
2012
|
0.78
|
|
34
|
Subclinical gut inflammation in ankylosing spondylitis.
|
Curr Opin Rheumatol
|
2016
|
0.77
|
|
35
|
The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome.
|
Expert Rev Clin Immunol
|
2014
|
0.76
|
|
36
|
Successful intravenous immunoglobulin treatment for steroid-resistant eosinophilic enteritis in a patient with systemic lupus erythematosus.
|
Clin Exp Rheumatol
|
2011
|
0.76
|
|
37
|
Intestinal dysbiosis and innate immune responses in axial spondyloarthritis.
|
Curr Opin Rheumatol
|
2016
|
0.75
|
|
38
|
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
39
|
Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects.
|
Metabolism
|
2003
|
0.75
|
|
40
|
PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease.
|
Clin Exp Rheumatol
|
2011
|
0.75
|
|
41
|
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
42
|
Alterations of the beneficial effect of deep inspiration in scleroderma: relationships between lung function and imaging.
|
Respiration
|
2008
|
0.75
|